Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The mobius strip, the cell, and soft logic mathematics.
Torday JS, Klein M, Maimon O. Torday JS, et al. Among authors: maimon o. Prog Biophys Mol Biol. 2024 Jan;186:65-70. doi: 10.1016/j.pbiomolbio.2023.12.002. Epub 2023 Dec 29. Prog Biophys Mol Biol. 2024. PMID: 38160943
Context-sensitive medical information retrieval.
Auerbuch M, Karson TH, Ben-Ami B, Maimon O, Rokach L. Auerbuch M, et al. Among authors: maimon o. Stud Health Technol Inform. 2004;107(Pt 1):282-6. Stud Health Technol Inform. 2004. PMID: 15360819
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells.
Granit Mizrahi A, Gugenheim A, Hamad H, Hamed R, Tetro N, Maimon O, Khutsurauli S, Nechushtan H, Nisman B, Duran D, Samman W, Birimberg-Schwartz L, Grunewald M, Eyal S, Peretz T. Granit Mizrahi A, et al. Among authors: maimon o. Front Cell Dev Biol. 2023 Oct 26;11:1217149. doi: 10.3389/fcell.2023.1217149. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37954205 Free PMC article.
In Response.
Nisman B, Oleinikov K, Nechushtan H, Maimon O, Atlan K, Peled N, Gross D, Peretz T, Meirovitz A, Grozinsky-Glasberg S. Nisman B, et al. Among authors: maimon o. J Thorac Oncol. 2023 Nov;18(11):e139-e141. doi: 10.1016/j.jtho.2023.08.032. J Thorac Oncol. 2023. PMID: 37879775 No abstract available.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
34 results